×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 

产品中心Cell Resources

联系我们CONTACT US

  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)

A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)

货号:CL-0255

规格:1×10⁶cells/T25培养瓶

价格: ¥1500

生长培养基:MEM(含NEAA)10% FBS1% P/S

数量: - +

  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
  • A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)

推荐搭配

套餐1:

A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确) ¥1500
A875 [A-875]细胞专用培养基
  • ¥350
  • ¥450

现单独购买该产品也可享受限时优惠价!

细胞培养最优解!

套餐组合价:¥1850¥1950

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 A875 [A-875] (人黑色素瘤细胞) (STR鉴定正确)
种属
生长特性 贴壁细胞
细胞形态 多角形
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
生长培养基:
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:3-1:6
推荐换液频率 2-3次/周
参考资料(来源文献)
背景描述 A875细胞NGF受体阳性,可用于建立动物研究模型。
年龄(性别) 女性;40岁
细胞类型 肿瘤细胞
肿瘤类型 黑色素瘤细胞
STR鉴定
  • STR位点信息
    Amelogenin X
    CSF1PO 11,12
    D2S1338 20,24
    D3S1358 14,15
    D5S818 11,13
    D7S820 8,11
    D8S1179 11
    D13S317 8,12
    D16S539 11,12
    D18S51 17
    D19S433 13.2,14
    D21S11 28,30.2
    FGA 22
    PentaD 10,12
    PentaE 7
    TH01 9.3
    TPOX 8,11
    vWA 15,16
    D6S1043 19
    D12S391 20,22
    D2S441 11
  • STR鉴定图
参考文献
文献列表
  • A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells (2024-01-02)

    作者:Chunyan Feng:1.Institute of Biopharmaceutical and Health Engineering, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, Guangdong, China. ; 2.School of Life Sciences, Tsinghua University, Beijing, 100084, China. ; Albert Yu:1.Institute of Biopharmaceutical and Health Engineering, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen, 518055, Guangdong, China. ; Zhongfu Wang:1.Department of Interventional Radiology, Shenzhen People's Hospital, 1017 Dongmen North Road, Shenzhen, 518020, NoGuangdong, China. ; Kun Wang:1.Institute of Biopharmaceutical and Health Engineering, Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen,

    期刊:A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells

    DOI:10.1186/s13046-023-02910-y

    影响因子 :11.3

    引用产品: A875 [A-875] 细胞 ,  293T [HEK-293T] 细胞 ,  SK-MEL-28 细胞

  • Envoplakin Inhibits Macrophage Polarization by Altering the Inflammatory Tumor Microenvironment of Melanoma Through the RAS / ERK Signaling Pathway (2024-03-14)

    作者:Weilin Cai:1.Medical School of Chinese PLA, Beijing, People's Republic of China. ; 2.Senior Department of Burns and Plastic Surgery, the Fourth Medical Center of PLA General Hospital, Beijing, People's Republic of China. ; Minliang Chen:1.Senior Department of Burns and Plastic Surgery, the Fourth Medical Center of PLA General Hospital, Beijing, People's Republic of China. ;

    期刊:Envoplakin Inhibits Macrophage Polarization by Altering the Inflammatory Tumor Microenvironment of Melanoma Through the RAS / ERK Signaling Pathway

    DOI:10.2147/JIR.S447934

    影响因子 :4.5

    引用产品: A-375 细胞 ,  A2058 细胞 ,  A875 [A-875] 细胞 ,  SK-MEL-28 细胞

  • Discovery of novel CDK2 inhibitors using multistage virtual screening and in vitro melanoma cell lines (2023-03-24)

    作者:Lihong Yang:1.State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Responses, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin, 300353, China. ; Mukuo Wang:1.State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Responses, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin, 300353, China. ; Beibei Li:1.State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for Cell Responses, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin, 300353, China. ; 2.Platform of Pharmaceutical Intelligence, Tianjin International Joint Academy of Biomedicine, Tianjin, 300457, China. ; Shangqin Xu:1.State Key Laboratory of Medicinal Chemical Biology, Fro

    期刊:Discovery of novel CDK2 inhibitors using multistage virtual screening and in vitro melanoma cell lines

    DOI:10.1096/fj.202201217RR

    影响因子 :4.8

    引用产品: Hacat 细胞 ,  A875 [A-875] 细胞

  • Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma (2023-07-04)

    作者:Jiaoquan Chen:1.Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, Guangdong, China. ; Nanji Yu:1.Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, Guangdong, China. ; Shanshan Ou:1.Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, Guangdong, China. ; Xue Wang:1.Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, Guangdong, China. ; Huaping Li:1.Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, Guangdong, China. ; Huilan Zhu:1.Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, 510095, Guangdong, China. zhlhuilan@126.com. ;

    期刊:Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma

    DOI:10.1007/s00432-023-05064-8

    影响因子 :3.6

    引用产品: A875 [A-875] 细胞

  • miR-767-3p suppresses melanoma progression by inhibiting ASF1B expression (2022-08-09)

    作者:Xian Shi:1.Department of Dermatology, Huangshi Central Hospital, Huangshi, 435000, Hubei, China. ; Xidan Xu:1.Department of Dermatology, Huangshi Central Hospital, Huangshi, 435000, Hubei, China. ; Nian Shi:1.Department of Dermatology, Huangshi Central Hospital, Huangshi, 435000, Hubei, China. ; Yongjun Chen:1.Department of Dermatology, Huangshi Central Hospital, Huangshi, 435000, Hubei, China. ; Manni Fu:1.Department of Dermatology, Huangshi Central Hospital, Huangshi, 435000, Hubei, China. Electronic address: fu_manni14@163.com. ;

    期刊:miR-767-3p suppresses melanoma progression by inhibiting ASF1B expression

    DOI:10.1016/j.bbrc.2022.08.014

    影响因子 :3.3

    引用产品: A875 [A-875] 细胞 ,  A-375 细胞 ,  A2058 细胞 ,  RPMI-1640 培养基 ,  DMEM高糖 培养基 ,  特级胎牛血清

  • USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axis (2002-01-20)

    作者:Min Li:1.Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic of China; Joint International Research Laboratory of Metabolic & Developmental Sciences, Shanghai Jiao Tong University, Shanghai, People's Republic of China. ; Yanqin Xu:1.Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic of China; Joint International Research Laboratory of Metabolic & Developmental Sciences, Shanghai Jiao Tong University, Shanghai, People's Republic of China. ; Jie Liang:1.Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic of China. ; Hao Lin:1.Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, People's Republic of Chi

    期刊:USP22 deficiency in melanoma mediates resistance to T cells through IFNγ-JAK1-STAT1 signal axis

    DOI:10.1016/j.ymthe.2021.02.018

    影响因子 :12.4

    引用产品: A875 [A-875] 细胞 ,  SK-MEL-1 细胞

  • Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src (2010-05-20)

    作者:Bingyu Guo:1.Reconstructive and Plastic Surgery, The General Hospital of Shenyang Military Region, 83#Wenhua Road, Shenhe District, Shenyang, Liaoning, 110016, People's Republic of China. ; Yu Zhang:1.Reconstructive and Plastic Surgery, The General Hospital of Shenyang Military Region, 83#Wenhua Road, Shenhe District, Shenyang, Liaoning, 110016, People's Republic of China. ; Qiang Hui:1.Reconstructive and Plastic Surgery, The General Hospital of Shenyang Military Region, 83#Wenhua Road, Shenhe District, Shenyang, Liaoning, 110016, People's Republic of China. ; Hongyi Wang:1.Reconstructive and Plastic Surgery, The General Hospital of Shenyang Military Region, 83#Wenhua Road, Shenhe District, Shenyang, Liaoning, 110016, People's Republic of China. ; Kai Tao:1.Reconstructive and Plastic Surgery, The General Hospital of Shenyang Military Region, 83#Wenhua Road, Shenhe District, Shenyang, Liaoning, 110016, People's Republic of China. luzongzhengxing@sina.com. ;

    期刊:Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src

    DOI:10.1007/s13277-015-4235-z

    影响因子 :0.0

    引用产品: A-375 细胞 ,  A875 [A-875] 细胞

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号